Skip to content
Review

Lactate as a metabolic–epigenetic hub in neurological disorders

Sep 2026 · Metabolic brain disease · Vol 41 · 0 citations · 72 references
Medicine

TL;DR

This comprehensive review synthesizes recent advances in lactate biology, encompassing the expanding enzymatic landscape of lactylation—including newly identified writers, erasers, and readers—and their roles in neurodegenerative diseases and critically re-examine metabolic coupling models beyond the classical astrocyte-neuron lactate shuttle.

View source

Similar papers

Review Sep 2026

Beyond Fuel: Metabolic Intermediates as Signaling Molecules in Neuroinflammation and Neurodegeneration.

The functions of α-KG, a central metabolic hub that links metabolic status to cellular identity and aging by epigenetically regulating DNA and histone demethylase activity, are highlighted, delineating a fundamental layer of biological regulation.

Song Wang, Si-Chen Wang, Yu-Han Sun et al. · 0 citations
Review Open access Sep 2026

Roles of glycolytic and pyruvate metabolism enzymes in Alzheimer’s disease glycometabolic reprogramming and their therapeutic potential

Current evidence regarding the dysregulation of major glycolytic and pyruvate-metabolizing enzymes, including hexokinase (HK), phosphofructokinase-1 (PFK1), pyruvate kinase (PK), lactate dehydrogenase (LDH), and the pyruvate dehydrogenase complex (PDHc), in both neurons and glial cells are synthesized.

Min-Min Chen, Chang-Min Zuo, Run-Zhi Li et al. · 0 citations
Review Sep 2026

Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation.

This review critically examines the molecular and spatial architecture of glucose metabolism in the parkinsonian brain and evaluates the therapeutic potential of emerging metabolic modulators, including terazosin, cordycepin, and GLP-1 receptor agonists.

Ying Yi, Cen Chen, You He et al. · 0 citations
Review Sep 2026

Lactate and lactylation in cancer: metabolic regulation, immune modulation, and therapeutic opportunities.

A deeper understanding of lactate flux and lactylation-dependent vulnerabilities may enable biomarker-guided combinations that integrate metabolic intervention, epigenetic modulation, and immuno-oncology for precision cancer therapy.

Jia-Yi Chen, An-Qi He, Si-Yi Zhu et al. · 0 citations
Review Aug 2026

Targeting metabolic reprogramming in cancer: Past, present, and future.

Cancer cells undergo profound metabolic reprogramming to sustain uncontrolled proliferation within a nutrient-limited and often hypoxic tumor microenvironment (TME). Metabolic rewiring is an active driver of oncogenesis, immune evasion, epigenetic remodeling, and therapy resistance. Over the past century, our understan...

Niti Kumari, Surendra K. Shukla, Ravi Thakur · 0 citations
Review Open access Aug 2026

Metabolism meets inflammation: lactate and lactylation in inflammatory pathogenesis

This review summarizes the metabolic mechanisms underlying lactate production and lactylation within the inflammatory microenvironment, and discusses how the lactate-lactylation axis relates to the dynamic “alteration-exudation-proliferation” trajectory of inflammation.

Xin Huang, Ya-Qiao Zhu, Ruiming Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.